Moderna CEO Talks Company Earnings
Bloomberg Talks
Introduction
Insights into Moderna's quarterly report, highlighting a slim profit outlook, cost-saving initiatives, and plans for an RSV vaccine approval. The CEO elaborates on balancing cost efficiency with innovation through new research ventures and strategic partnerships.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
